Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorhexidine- and isopropyl alcohol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorhexidine gluconate 2%/isopropyl alcohol 70% topical sponge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ammonium lactate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ammonium lactate 1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Podophyllotoxin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methyl salicylate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasone butyrate+oxytetracycline+nystatin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluprednidene- and miconazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluprednidene acetate 1 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Podofilox preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200mg/sup pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+calcipotriol (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aserbine |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Application of moisturizer to skin |
Direct substance |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Application of cream to skin (procedure) |
Direct substance |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Application of topical agent to skin |
Direct substance |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Application of egg white to female perineal area |
Direct substance |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorhexidine gluconate 20 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole 4% vaginal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing delmopinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Delmopinol 0.2% oral rinse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
agent topique cutané |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gamolenic acid (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
agent photosensibilisant |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terconazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing butoconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely terconazole 4 milligram/1 milliliter conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely terconazole 8 milligram/1 milliliter conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terconazole 80 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Butoconazole nitrate 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorhexidine gluconate 3.15%/isopropyl alcohol 70% topical swab |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chlorhexidine and chlorobutanol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Undecylenic acid and undecylenate salt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulconazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing terbinafine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metronidazole+nystatin 400mg/10000units tablet+pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 500,000units tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin GF/LF/SF 100,000units/mL suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terbinafine (as terbinafine hydrochloride) 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Econazole nitrate 150mg/1% pessaries+cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely econazole nitrate 150 milligram/1 each conventional release vaginal pessary (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 100mg pessary (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 100mg/2% pessary+cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100,000units pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Kaolin poultice BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100,000units pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexetidine 0.1% mouthwash (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Econazole nitrate 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 2% dusting powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulconazole nitrate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brilliant green+crystal violet 0.5%/0.5% paint BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Crystal violet 0.5% paint BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylrosanilinium chloride 10 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terbinafine hydrochloride 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200mg/2% pessary/2%cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole 1200mg vaginal insert/miconazole 2.0% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasone butyrate+oxytetracycline+nystatin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clioquinol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing econazole and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone- and nystatin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamcinolone+econazole (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Econazole 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate 10 mg/g cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical nystatin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical miconazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 1.2g pessary (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clobetasone butyrate+oxytetracycline+nystatin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing naftifine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Local anti-infective |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing econazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hexetidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|